In Molt-4 cells, thymosin beta4 was commonly decreased after apoptosis was induced by etoposide, ICRF-193 and neocarzinostatin.
In plain wordsIn cells, the body's own thymosin beta4 fell when anticancer drugs caused cell death.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- DecreaseThymosin beta4 level during apoptosis
- Study
humann: not reported in source
Molt-4 cells- Outcome group
- Tumor growth · Cancer
Source sentences
Following the induction of apoptosis, a low molecular weight protein that was identified to be thymosin beta4 by HPLC analysis was commonly decreased, and the morphology of actin filaments changed into clump formations.
1 context sentence(design, population, supporting numbers)
When Molt-4 cells were exposed to the antitumor drugs etoposide, meso-2,3-bis(3,5-dioxopiperazine-1-yl)butane (ICRF-193), and neocarzinostatin, they exhibited apoptotic cell death as determined by flow cytometry using fluorescein isothiocyanate (FITC)-labeled annexin V staining of phosphatidylserine…
This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.